Epac2抗体;Epac2 Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of Epac2 expression in Human fetal brain lysate.    

  
  

The Epac2 (Exchange Protein Activated by cAMP 2) antibody is a critical tool for studying the cAMP signaling pathway, which regulates diverse cellular processes such as metabolism, secretion, and gene expression. Epac2. also known as RAPGEF4. is a guanine nucleotide exchange factor activated by cyclic AMP (cAMP), functioning independently of the classical protein kinase A (PKA) pathway. It modulates intracellular signaling by activating small GTPases like Rap1 and Rap2. thereby influencing cell adhesion, differentiation, and synaptic plasticity.

Epac2 is highly expressed in brain regions (e.g., hippocampus, hypothalamus), pancreatic β-cells, and endocrine tissues, making it a focus in diabetes and neurological disorder research. In pancreatic β-cells, Epac2 mediates cAMP-enhanced insulin secretion, linking it to type 2 diabetes pathophysiology. Dysregulation of Epac2 has also been implicated in neuropsychiatric conditions, including autism spectrum disorders and Alzheimer’s disease.

Antibodies targeting Epac2 enable researchers to detect its expression, localization, and interaction partners via techniques like Western blotting, immunohistochemistry, and co-immunoprecipitation. Specificity and validation (e.g., knockout controls) are crucial due to structural similarities with Epac1 (RAPGEF3). These antibodies have advanced studies on cAMP-Epac2 signaling in disease models, drug discovery, and mechanistic explorations of cellular responses to hormones and neurotransmitters. Their development underscores the importance of Epac2 as a therapeutic target and biomarker in metabolic and neurological diseases.